Article Details

Biotech startup Kineta inks cancer deal with Pfizer worth up to $505M

Retrieved on: 2018-12-16 20:56:15

Tags for this article:

Click the tags to see associated articles and topics

Biotech startup Kineta inks cancer deal with Pfizer worth up to $505M. View article details on hiswai:

Excerpt

<div>Business intelligence group <b>CB Insights</b> recently named Kineta one of its “Game Changing Startups” for 2019 for its non-opioid pain program.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up